Mounjaro vs Zepbound: same drug, different job
Mounjaro and Zepbound are the same medicine (tirzepatide) sold under two brand names. Mounjaro is FDA-approved for type-2 diabetes. Zepbound is FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnoea in adults with obesity. The dose strengths, the pen, the side effects and the risks are identical. The honest difference is the approved use, not the drug inside. This article explains what that means for you in India, and why your doctor, not the brand name, decides what fits your case.
Unlock the complete article
Register with just your mobile number and OTP. No password and no payment.